HIGHLIGHTS
- who: TYPE et al. from the Centre for Genomic Regulation (CRG), Spain Barts Cancer Institute, Queen Mary University of London, London, EC M BQ, United Kingdom have published the article: Amoeboid migration in health and disease: Immune responses versus cancer dissemination, in the Journal: (JOURNAL)
- future: Strategies to Frontiers in Cell and Developmental Biology Discussion and future directions There are important parallels between amoeboid leukocyte and tumour cell migration driven by both cytokine signalling and Rho-ROCK activation. Differentiation therapies targeting amoeboid cancer stem_cells could halt tumour progression and prevent relapse but more work is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.